Skip to Main Content

Paper Details

Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.
Cancer Discov
13
2023
CD8+, CD8+ T cells, CX3CR1, CX3CR1+, GBM, Glioblastoma, Microglial, NR4A2, Nr4a2, Nr4a2+/-, Nr4a2fl/flCx3cr1Cre, SQLE, brain cancer, cholesterol, immunologically cold brain tumor, microglia, nuclear receptor subfamily 4 group A member 2, primary brain tumor, squalene, squalene monooxygenase, tumor
Author NameAffiliation
Zhixin QiuUniversity of Pittsburgh Medical Center Hillman Cancer Center
Hao HuangSoutheast University
Xin WangThe Chinese University of Hong Kong, Prince of Wales Hospital
Michael D TaylorThe Hospital for Sick Children
Michael D TaylorThe Hospital for Sick Children
Michael D TaylorThe Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Michael D TaylorThe Hospital for Sick Children
Michael D TaylorThe Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Michael D TaylorThe Hospital for Sick Children
Jeremy N RichUniversity of Pittsburgh Medical Center Hillman Cancer Center
Jeremy N RichUniversity of Pittsburgh Medical Center
Jeremy N RichUniversity of Pittsburgh Medical Center Hillman Cancer Center
Jeremy N RichUniversity of Pittsburgh Medical Center
  • 1 - 13

Datasets